Published in Clin Exp Immunol on April 01, 1976
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med (1977) 4.59
Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics. Gut (1979) 1.88
The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity. Immunology (1979) 1.08
The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function. Clin Exp Immunol (1977) 1.02
Leucocyte capillary migration: an adherence dependent phenomenon. Clin Exp Immunol (1976) 0.98
Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes. J Exp Med (1979) 0.96
In vitro reversal of cellular unresponsiveness induced by levamisole. Clin Exp Immunol (1976) 0.91
Stimulation of capillary tube polymorph migration: an indirect glucocorticoid effect on microtubular function. Clin Exp Immunol (1978) 0.89
Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy. Clin Exp Immunol (1981) 0.88
Biology of primate relaxin: a paracrine signal in early pregnancy? Reprod Biol Endocrinol (2004) 0.87
Involvement of prostaglandin E1 in delayed-type hypersensitivity suppression induced with live Mycobacterium bovis BCG. Infect Immun (1982) 0.86
Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes. Clin Exp Immunol (1984) 0.84
Regulation of allergic responses by prostaglandins: a review. J R Soc Med (1980) 0.81
The role of locomotion in lymphocyte migration. Immunology (1979) 0.79
In vivo induction of neutrophilia, lymphopenia, and diminution of neutrophil adhesion by stable analogs of prostaglandins E1, E2, and F2 alpha. Am J Pathol (1986) 0.78
Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand (1967) 7.97
Inhibition of granulocyte adherence by ethanol, prednisone, and aspirin, measured with an assay system. N Engl J Med (1974) 3.39
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol (1974) 2.53
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest (1975) 2.40
Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation. Proc Soc Exp Biol Med (1970) 2.30
The role of cyclic AMP in the cytolytic activity of lymphocytes. J Immunol (1971) 1.78
Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol (1973) 1.64
The effect of 3',5'-adenosine monophosphate on granulocyte adhesion. J Clin Invest (1974) 1.17
Cyclic AMP affects macrophage migration. Nat New Biol (1972) 1.14
Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes. Clin Exp Immunol (1975) 1.02
Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogues: possible role of cyclic AMP. J Lab Clin Med (1972) 0.99
Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs. Immunology (1974) 0.92
Role of cyclic AMP in mitogen induced transformation of human peripheral leukocytes. J Immunol (1973) 0.87
Cyclic AMP inhibition of cytotoxin ("lymphotoxin") elaboration by stimulated lymphocytes. Cell Immunol (1973) 0.86
Emergence of multiply resistant pneumococci. N Engl J Med (1978) 8.32
Detection of enteric campylobacteriosis in children. J Clin Microbiol (1979) 4.57
Generalized Yersinia enterocolitica infection. J Infect Dis (1975) 3.55
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians (1976) 3.49
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
Protective efficacy of pneumococcal polysaccharide vaccines. JAMA (1977) 2.83
Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disc diffusion test for detection of penicillin G resistance. J Antimicrob Chemother (1980) 2.73
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions. Antimicrob Agents Chemother (1985) 2.71
Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis (1988) 2.69
Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2.59
Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob Agents Chemother (1979) 2.32
Enterotoxin production in relation to taxonomic grouping and source of isolation of Aeromonas species. J Clin Microbiol (1984) 2.27
Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother (1979) 2.17
Invasive potential of noncytotoxic enteropathogenic Escherichia coli in an in vitro Henle 407 cell model. Infect Immun (1989) 1.77
A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol (1995) 1.76
In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils. J Immunol (1976) 1.76
Production of a suppressor factor by human adherent cells treated with mycobacteria. J Immunol (1980) 1.72
Mechanism of action of Yersinia enterocolitica enterotoxin. Infect Immun (1979) 1.61
Corneal ulceration at an urban African hospital. Br J Ophthalmol (1985) 1.59
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine (1996) 1.59
Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child (1986) 1.55
Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med (1985) 1.54
A microbiological study of gastro-enteritis in Black infants. S Afr Med J (1977) 1.51
Generalized infection with Yersinia enterocolitica and the role of iron. Contrib Microbiol Immunol (1979) 1.50
Campylobacter infections in Soweto. S Afr Med J (1979) 1.49
The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels. J Immunol (1977) 1.49
Letter: Viruses in acute summer gastroenteritis in black infants. Lancet (1975) 1.43
Causes and treatment of sexually acquired genital ulceration in southern Africa. S Afr Med J (1989) 1.43
Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic properties. Infect Immun (1977) 1.43
Differentiation of sarcoidosis from tuberculosis using an enzyme-linked immunosorbent assay for the detection of antibodies against Mycobacterium tuberculosis. Chest (1988) 1.42
Fecal bacteria in South African rural blacks and other population groups. Isr J Med Sci (1979) 1.42
Enzyme-linked immunosorbent assay for the detection of antibodies against Mycobacterium tuberculosis in bronchial washings and serum. Chest (1988) 1.39
Discordant occurrence of primary biliary cirrhosis in monozygotic twins. N Engl J Med (1994) 1.39
Epidemiology of rheumatic heart disease in black shcoolchildren of Soweto, Johannesburg. Br Med J (1975) 1.39
Letter: Nitroblue tetrazolium test (NBT) in the investigation of febrile patients. S Afr Med J (1973) 1.38
Factors associated with airway colonisation and invasion due to Klebsiella spp. S Afr Med J (1993) 1.38
The recent cholera outbreak in the South African gold mining industry. A preliminary report. S Afr Med J (1974) 1.37
Accuracy of clinical diagnosis of genital ulcer disease. Sex Transm Dis (1991) 1.35
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents. Eur J Clin Microbiol (1984) 1.34
Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg. Antimicrob Agents Chemother (1982) 1.33
Yersinia enterocolitica infections in South Africa. S Afr Med J (1972) 1.31
Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis (1999) 1.28
In vitro susceptibility and cross-resistance of South African isolates of Neisseria gonorrhoeae to 14 antimicrobial agents. Antimicrob Agents Chemother (1982) 1.26
Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest (1976) 1.23
Rapid detection and species identification of mycobacteria in paraffin-embedded tissues by polymerase chain reaction. Diagn Mol Pathol (1992) 1.22
Bacteremia caused by a lactose-fermenting, multiply resistant Salmonella typhi strain in a patient recovering from typhoid fever. J Clin Microbiol (1987) 1.21
Neonatal septicemia and meningitis due to Aeromonas shigelloides. J Pediatr (1978) 1.21
Summer diarrhoea in African infants and children. Arch Dis Child (1980) 1.20
Carriage of penicillin resistant pneumococci. Arch Dis Child (1986) 1.20
Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol (1984) 1.20
Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr (1976) 1.19
Defective neutrophil motility in children with measles. J Pediatr (1976) 1.17
Immunologic studies in patients with recurrent bronchopulmonary infections. Am Rev Respir Dis (1975) 1.16
Dissociation of lymphokine production and blastogenesis in children with measles infections. Clin Immunol Immunopathol (1978) 1.16
Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother (1998) 1.13
In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis (1992) 1.12
Age related susceptibility to Campylobacter jejuni infection in a high prevalance population. Arch Dis Child (1983) 1.12
Characterization of a suppressor cell-activating factor (SCAF) released by adherent cells treated with M. tuberculosis. J Immunol (1983) 1.12
T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun (1976) 1.10
Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J (1974) 1.10
Worldwide increase in pneumococcal antibiotic resistance. Lancet (1989) 1.08
The prevalence of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect (1993) 1.08
Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond) (1984) 1.08
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages. AIDS (1993) 1.07
The Widal test in the diagnosis of typhoid fever in the transvaal. S Afr Med J (1981) 1.07
Etiology of infantile enteritis in South Africa. Isr J Med Sci (1979) 1.07
A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol (1994) 1.06
In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens. Antimicrob Agents Chemother (1986) 1.05
In vitro selection of bacteria resistant to LY146032, a new cyclic lipopeptide. Antimicrob Agents Chemother (1988) 1.03
Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother (1990) 1.03
Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes. Clin Exp Immunol (1975) 1.02
The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function. Clin Exp Immunol (1977) 1.02
Lack of suppressor cell activity in systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.02
Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration (1991) 1.01
Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core. Intensive Care Med (1989) 1.01
Intra- and inter-specific transformation of Streptococcus pneumoniae to penicillin resistance. J Antimicrob Chemother (1990) 1.00
Wound colonization by Ewingella americana. J Clin Microbiol (1986) 1.00
A simple medium for the primary isolation of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis (1992) 1.00
Hepatosplenic abscesses due to Yersinia enterocolitica. Br Med J (1972) 0.99
Leucocyte capillary migration: an adherence dependent phenomenon. Clin Exp Immunol (1976) 0.98
Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci (1999) 0.98
Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole. Cancer (1982) 0.98
An inhibitor of lymphocyte proliferation and lymphokine production released by unstimulated foetal monocytes. Clin Exp Immunol (1977) 0.97
Long-term infections with Campylobacter fetus subsp. jejuni. J Clin Microbiol (1981) 0.97
The risk of infection from Giardia lamblia due to drinking water supply, use of water, and latrines among preschool children in rural Lesotho. Int J Epidemiol (1989) 0.97
Plasmid-mediated NAD independence in Haemophilus parainfluenzae. J Gen Microbiol (1991) 0.97